Changchun Huapu Biotechnology Co., Ltd. announced that it has entered into a capital increase agreement for private placement of common shares for gross proceeds of CNY 40,000,000 on December 15, 2017. The transaction will include participation from new investor Changsheng Bio-Technology Co., Ltd. (SZSE:002680) to acquire 10.256% stake in the company. Out of the total amount, CNY 1,402,116 will be added to the registered capital and CNY 38,597,884 will be added to the capital reserve. The registered capital of the company will increase from CNY 12,268,518 to CNY 13,670,634. The transaction is not subject to board of directors’ approval and shareholders’ approval of the investor. The company has reported total assets of CNY 61,069,970.63, total liabilities of CNY 1,156,685.28, shareholders’ equity of CNY 59,913,285.35, and net loss of CNY 3,808,362.46 for the year ended December 31, 2016.